跳至主要内容
临床试验/NCT00923260
NCT00923260已完成不适用

Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran0 个研究点目标入组 24 人开始时间: 2005年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
主要终点
Components of Metabolic Syndrome (Body Mass Index)

研究概览

简要总结

The aim of the present study was to evaluate the additional effect of sudden visceral fat reduction by omentectomy on Metabolic Syndrome, acute phase reactants and inflammatory mediators in patients with morbid obesity undergoing Laparoscopic Roux-en-Y Gastric Bypass.

详细描述

Although weight loss controls Metabolic Syndrome and reduces the level of inflammatory markers in patients with Morbid Obesity, patients may enjoy the benefit achieving metabolic control before significant weight loss occurs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI > 35 Kg/m2
  • Metabolic syndrome diagnosed

排除标准

  • Type 1 diabetes
  • Uncontrolled type 2 diabetes
  • Cirrhosis or active hepatitis
  • Pregnancy
  • Recent MI or stroke

结局指标

主要结局

Components of Metabolic Syndrome (Body Mass Index)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Systolic Blood Pressure)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Triglycerides)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Low-Density Lipoproteins)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Diastolic Blood Pressure)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Total Cholesterol)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Glucose)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (Insulin)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

Components of Metabolic Syndrome (High-Density Lipoproteins)

时间窗: 1 year

Absolute values are presented, a basal value is provided in a previous outcome measure to determine the improvement.

次要结局

  • Acute Phase Reactants and Inflammatory Mediators (Interleukine-6)(1 year)
  • Acute Phase Reactants and Inflammatory Mediators (C-reactive Protein)(1 year)
  • Acute Phase Reactants and Inflammatory Mediators (Tumor Necrosis Factor-alpha)(1 year)
  • Acute Phase Reactants and Inflammatory Mediators (Leptin)(1 year)
  • Acute Phase Reactants and Inflammatory Mediators (Adiponectin)(1 year)

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other

相似试验